Genetically encoding the site-specific co-translational incorporation of noncanonical amino acids into proteins in eukaryotic cells and animals has provided numerous strategies for imaging and controlling the functions of proteins in their native environment.^[@ref1]^ Extensions of these approaches have enabled the tagging and labeling of cell-specific proteomes via stochastic orthogonal recoding of translation (SORT).^[@ref2]−[@ref5]^

The incorporation of ncAAs into proteins relies on the development of orthogonal aminoacyl-tRNA synthetase (aaRS)/tRNA pairs: the orthogonal aaRS selectively recognizes its cognate orthogonal tRNA over endogenous tRNAs, and the orthogonal tRNA is a substrate for the orthogonal aaRS but a poor substrate for endogenous synthetases. Because the sets of endogenous synthetases and tRNAs differ between organisms, aaRS pairs that are orthogonal in one system are commonly not orthogonal in another.^[@ref1]^ For example, the *Methanocaldococcus janaschii* (*Mj*) TyrRS pair that has been extensively used for genetic code expansion in *Escherichia coli* (*Ec*) cannot be used for genetic code expansion in eukaryotic cells because it is not orthogonal with respect to endogenous eukaryotic aaRS/tRNA pairs.

The *Ec*TyrRS/^Tyr^tRNA^[@ref6],[@ref7]^ pair and *Ec*LeuRS/^Leu^tRNA pair^[@ref8]^ are orthogonal in eukaryotic cells, and variants of these pairs have been discovered, primarily by directed evolution in yeast or subsequent screening, that enable the incorporation of a range of ncAAs in eukaryotic systems. The PylRS/^Pyl^tRNA pair from *Mm* is commonly considered an ideal pair for genetic code expansion because it is orthogonal in both *E. coli* and eukaryotic cells and animals.^[@ref1]^ This has facilitated the discovery and characterization of *Mm*PylRS variants that incorporate ncAAs in *E. coli* and the transfer of these variants to eukaryotic systems, thereby facilitating genetic code expansion in eukaryotic cells and animals. Recent work has demonstrated that an evolved SepRS/^v1.0/Sep^tRNA^v1.0^ pair enables the efficient incorporation of phosphoserine and its nonhydrolyzable analogue,^[@ref9]^ can be further evolved to incorporate phosphothreonine in *E. coli*,^[@ref10]^ and is also orthogonal in mammalian cells.^[@ref11]^ The ability to incorporate ncAAs into proteins in mammalian cells has been further expanded by strategies that replace the genomically encoded *Ec*TrpRS/^Trp^tRNA pair in *E. coli* with the *Saccharomyces cerevisiae* (*Sc*) TrpRS/^Trp^tRNA pair.^[@ref12]−[@ref14]^ Because the *Sc*TrpRS/^Trp^tRNA is orthogonal in *E*. *coli*, suppressor derivatives of the *Ec*TrpRS/^Trp^tRNA pair can be introduced into the resulting *E. coli* strains and evolved for ncAA incorporation. The resulting *Ec*TrpRS/^Trp^tRNA pairs can then be used for genetic code expansion in mammalian cells, where they are orthogonal. Recent work has extended this strategy to the *Ec*TyrRS/ ^Tyr^tRNA pair.^[@ref15]^ In several cases, aaRS/tRNA pairs that are active and orthogonal with respect to the endogenous aaRSs and tRNAs in mammalian cells have also been shown to be orthogonal with respect to other orthogonal pairs, creating "mutually orthogonal" pairs in mammalian cells.^[@ref16]−[@ref18]^

We recently discovered that a new class of PylRS/^Pyl^tRNA pairs from *Methanomassiliicocales* are active and orthogonal in *E. coli*.^[@ref19],[@ref20]^ These pairs, unlike the *Mm*PylRS/*Mm*^Pyl^tRNA pair, lack the N-terminal domain of PylRS, which was previously thought to be essential for tRNA recognition and aminoacylation.^[@ref21],[@ref22]^ We showed that certain orthogonal pairs from this class are naturally mutually orthogonal to the *Mm*PylRS;^[@ref19]^ this surprising result demonstrated that there is sufficient divergence between archeal PylRS/^Pyl^tRNA pairs to generate mutually orthogonal pairs for the same amino acid within a domain of life. We developed a number of exceptionally active and orthogonal pairs, including the *Ma*PylRS/*Ma*^Pyl^tRNA(6) pair, that are mutually orthogonal to the *Mm*PylRS/*Mm*^Pyl^tRNA pair by virtue of mutations introduced into the body of *Ma*^Pyl^tRNA.^[@ref19]^ Moreover, we showed that, because the active sites of *Mm*PylRS and *Ma*PylRS share common substrate recognition determinants, we could transplant mutations that direct the selective incorporation of specific ncAAs from the *Mm*PylRS active site to the *Ma*PylRS active site to reprogram its substrate specificity.^[@ref19]^ Finally, we showed that by diverging the active sites of *Ma*PylRS and *Mm*PylRS to selectively recognize distinct substrates and altering the anticodons of *Ma*^Pyl^tRNA(6) and *Mm*^Pyl^tRNA to decode distinct codons in orthogonal translation, we could use these pairs in the same cell to direct the incorporation of two distinct ncAAs into a single polypeptide.^[@ref19]^ Here we show that the *Ma*PylRS*/Ma*^Pyl^tRNA(6) pair is highly active and orthogonal in mammalian cells, where it is also mutually orthogonal to the *Mm*PylRS/*Mm*^Pyl^tRNA pair ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), and that derivatives of the two pairs can be used together to incorporate distinct amino acids into a protein in mammalian cells.

![The evolved *Ma*PylRS/*Ma*^Pyl^tRNA(6) is orthogonal with respect to the endogenous *E. coli* aaRS/tRNA pairs as well as mutually orthogonal to the *Mm*PylRS/*Mm*^Pyl^tRNA(6) pair. Here we ask if this pair is also orthogonal and mutually orthogonal in mammalian cells. NTD (N-terminal domain).](bi-2018-008089_0001){#fig1}

We first demonstrated that the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is active in mammalian cells and that both *Ma*PylRS and *Ma*^Pyl^tRNA(6)~CUA~ are orthogonal with respect to the endogenous tRNAs and the aaRSs in human cells. To this aim, we cloned coding sequences of *Ma*PylRS and *Ma*^Pyl^tRNA(6)~CUA~ into a vector for mammalian expression;^[@ref23]^ we cloned *Ma*PylRS under the EF1a promoter and four copies of the *Ma*^Pyl^tRNA(6)~CUA~ under the human U6 promoter into the same vector. We transiently co-transfected HEK293 cells with the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ vector and an mCherry-TAG-GFP reporter^[@ref11]^ and cultured the resulting cells in the presence or absence of Nε-\[(*tert*-butoxy)carbonyl\]-[l]{.smallcaps}-lysine (BocK), a known substrate for this pair.^[@ref19]^ We measured the ratio of GFP to mCherry fluorescence by flow cytometry ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a and [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b00808/suppl_file/bi8b00808_si_001.pdf)) and fluorescence microscopy ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b00808/suppl_file/bi8b00808_si_001.pdf)) and performed control experiments with the well-characterized *Mm*PylRS/^Pyl^tRNA~CUA~ pair.

![The *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is active and orthogonal in mammalian cells. (a) *Ma*PylRS and *Mm*PylRS show comparable, BocK-dependent, readthrough of the amber stop codon with their cognate tRNAs. Data represent means ± the standard deviation from two biological replicates. (b) ESI-MS of purified sfGFP confirms quantitative incorporation of BocK via the *Mm*PylRS/*Mm*^Pyl^tRNA~CUA~ pair. (c) ESI-MS of purified sfGFP confirms quantitative incorporation of BocK via the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair.](bi-2018-008089_0002){#fig2}

We observed minimal readthrough of the amber codon by the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair in the absence of BocK ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a**)**. This demonstrates that *Ma*^Pyl^tRNA(6)~CUA~ is orthogonal with respect to the aminoacyl-tRNA synthetases that are endogenous in human cells. Upon addition of 0.5 and 1 mM BocK, we observed substantial readthrough of the TAG codon by the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair. The level of amber codon readthrough mediated by the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is comparable to that mediated by the highly active *Mm*PylRS/*Mm*^Pyl^tRNA~CUA~ pair ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a); this demonstrates that the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is highly active in mammalian cells.

To demonstrate that *Ma*PylRS is functionally orthogonal in human cells, we co-transfected plasmids encoding the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair and *GFP(150TAG)His*~6~ and cultured the cells in the presence of 1 mM BocK. ESI-MS of the resulting GFP gives the expected mass ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b) and is indistinguishable from a control in which we used the *Mm*PylRS/*Mm*^Pyl^tRNA~CUA~ pair to incorporate BocK into *GFP(150TAG)His*~6~ ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c). Taken together, our experiments reveal that the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is a highly active and orthogonal pair in mammalian cells.

Next, we aimed to demonstrate that the *Mm*PylRS/*Mm*^Pyl^tRNA~CUA~ pair and *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair are mutually orthogonal in their aminoacylation specificity when expressed in mammalian cells. We swapped the 4× U6-tRNA cassette between the *Mm* and *Ma* expression vectors producing a plasmid containing the *Mm*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair and a plasmid containing the *Ma*PylRS/*Mm*^Pyl^tRNA~CUA~ pair. We co-transfected the mCherry-TAG-GFP reporter with each aaRS/tRNA combinations and cultured the cells in the presence and absence of BocK. We compared the readthrough of the amber stop codon by these noncognate pairs to that mediated by the *Mm*- and *Ma*-derived cognate pairs ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Our data show that the noncognate *Mm*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ and *Ma*PylRS/*Mm*^Pyl^tRNA~CUA~ pairs lead to minimal readthrough of the amber stop codon ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a), while the cognate pairs lead to efficient amber suppression ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). This demonstrates that these two PylRS/^Pyl^tRNA~CUA~ pairs are mutually orthogonal in mammalian cells.

![The *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is mutually orthogonal to the *Mm*PylRS/*Mm*^Pyl^tRNA~CUA~ pair in mammalian cells. *Ma*PylRS and *Mm*PylRS show comparable, BocK-dependent aminoacylation of their cognate tRNA and minimal cross-aminoacylation of the noncognate ^Pyl^tRNA~CUA~. Data represent means ± the standard deviation from two biological replicates.](bi-2018-008089_0003){#fig3}

Next we differentiated the active sites of *Ma*PylRS and *Mm*PylRS such that they selectively recognize distinct substrates. By screening a collection of *Ma*PylRS mutants for non-natural substrate specificity in *E. coli*, we discovered a variant of *Ma*PylRS, *Ma*PylRS(mut), that incorporates 3-methyl-[l]{.smallcaps}-histidine (Me-His) but not BocK; this synthetase contains L121M, L125I, Y126F, M129A, and V168F mutations. We find that *Mm*PylRS directs the incorporation of BocK but not Me-His; these specificities are maintained in mammalian cells ([Figure S3a](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b00808/suppl_file/bi8b00808_si_001.pdf)). Finally, we performed a double incorporation of BocK and Me-His into GFP(101TGA,150TAG) using the *Mm*PylRS*/Mm*^Pyl^tRNA~CAU~ and *Ma*PylRS(mut)/*Ma*^Pyl^tRNA(6)~CUA~ pairs. Production of full-length protein was dependent on addition of both ncAAs ([Figure S3b](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b00808/suppl_file/bi8b00808_si_001.pdf)), consistent with the site-specific incorporation of both amino acids into GFP in mammalian cells.

We have demonstrated that the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is orthogonal with respect to the synthetases and tRNAs present in mammalian cells and is highly active in mammalian cells. As the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair is also orthogonal in *E. coli* and we have demonstrated that mutations discovered in the active site of *Mm*PylRS or *Mb*PylRS can be transplanted into *Ma*PylRS to reprogram its substrate specificity,^[@ref19]^ it will be possible to rapidly expand the substrate scope of the *Ma*PylRS/*Ma*^Pyl^tRNA(6)~CUA~ pair. Moreover, as *Ma*PylRS is a single-domain protein that lacks the poorly soluble N-terminal domain of *Mm*PylRS, it may be even more amenable to directed evolution in *E. coli* than the *Mm*PylRS system. Our results demonstrate that *Ma*PylRS mutants discovered and characterized in *E. coli* will be of direct utility in mammalian cells.

Finally, we have confirmed that the mutual orthogonality of the *Mm*PylRS/*Mm*^Pyl^tRNA pair and *Ma*PylRS/*Ma*^Pyl^tRNA(6) pair, which we have characterized in *E. coli*, is maintained in mammalian cells and shown that these pairs can be used together for (unoptimized) double incorporation. These are therefore the first mutually orthogonal pairs in which each pair is itself orthogonal in both *E. coli* and eukaryotic systems. We anticipate that this foundational advance will facilitate multiplexed proteome labeling.^[@ref2]−[@ref5]^ Combinations of the advances reported herein, together with strategies for creating additional blank codons and increasing the efficiency of multisite ncAA incorporation in mammalian cells, may facilitate the site-specific incorporation of diverse, and currently inaccessible, combinations of ncAAs into proteins in mammalian cells.^[@ref16]−[@ref18]^

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.biochem.8b00808](http://pubs.acs.org/doi/abs/10.1021/acs.biochem.8b00808).Experimental methods and supplementary figures ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b00808/suppl_file/bi8b00808_si_001.pdf))
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